Drug policy reform groups pillory Grassley and Feinstein for holding an anti-legalization hearing while bipartisan medical marijuana legislation languishes.
Read article here: High Times
Drug policy reform groups pillory Grassley and Feinstein for holding an anti-legalization hearing while bipartisan medical marijuana legislation languishes.
Read article here: High Times